glp 1 small bowel obstruction Fixing GLP-1 Constipation Association of GLP-1 receptor agonists

This decision raises important questions about safety, access, and the best treatment options for weight management.

Weight is the primary metric by which anti-obesity drugs are judged and distributed, but weight and BMI are poor measures for visceral fat

Power at 230 V: 1,200 W

Nicola Magrini, Unit head for Innovation, Evidence synthesis and Clinical research, University Hospital, Bologna, Italy, Co-Chair of the Guidelines Development GroupComments: GLP-1 and inclusion in the essential medicineMr Deus Mubangizi, Director, Medicines and Health Products Policies and Standards Department, WHOPanel discussionMs Jeanette Hunter General Primary Health Care at the National Department of Health (NDoH) of South Africa, and Co-Chair of the Guidelines Development Group